By TransPerfect Life Sciences
Recently at the DIA Europe Annual Meeting in Vienna, TransPerfect—together with ICON Clinical Research—led an “Automated Translations Workshop” to discuss how companies can transform the translation process using technology and artificial intelligence to work more efficiently and get drugs to market faster. As the industry becomes more global, companies are dealing with larger and larger sets of data and documents that are required in a wider variety of languages. As the volume of content grows, it becomes even more important for companies to evaluate their translation processes in order to produce more global content, while utilizing fewer resources. By introducing efficiency into the translation process, pharma companies can work to more quickly enroll patients in trials and bring new drugs to market.